Mesenchymal stem cell
Mesenchymal stem cells (MSCs), also called mesenchymal stromal cells or multipotent stromal cells, are a multipotent, plastic-adherent cell type resident in the stromal compartment of many tissues — most prominently bone marrow, umbilical cord, adipose tissue, and the dental pulp of exfoliated deciduous teeth (the source of SHED).
Mesenchymal stem cells (MSCs), also called mesenchymal stromal cells or multipotent stromal cells, are a multipotent, plastic-adherent cell type resident in the stromal compartment of many tissues — most prominently bone marrow, umbilical cord, adipose tissue, and the dental pulp of exfoliated deciduous teeth (the source of SHED). They act as progenitor and support cells rather than terminally differentiated cells: they can differentiate along osteogenic, chondrogenic, and adipogenic lineages, and under defined stimulation can be directed toward other fates, including insulin-producing cells. In their native niche, MSCs help build the microenvironment that sustains neighboring populations; in bone marrow they contribute to the stromal network supporting hematopoietic stem cell retention and maintenance. Preparations are frequently named by tissue of origin — bone marrow–derived (BMSC), umbilical cord–derived (UC-MSC), and SHED — and clinical material is often obtained from concentrated bone marrow aspirate.
The therapeutic interest in MSCs rests less on direct structural replacement of damaged tissue than on their immunomodulatory and trophic activity. MSCs secrete a broad range of bioactive factors and release extracellular vesicles, including exosomes carrying microRNAs and proteins, that act on surrounding cells in a paracrine fashion — dampening proinflammatory cytokine signaling such as Tnf-α, limiting oxidative stress and reactive oxygen species, and engaging survival and growth signaling through the PTEN/Phosphatidylinositol 3-kinase (PI3K)/Protein kinase B (PKB)/mTOR axis. This repertoire underlies the range of conditions in which MSC transplantation has been explored: inflammatory and immune-mediated disease, chronic renal insufficiency, diabetes, myocardial infarction, spinal cord and other neurological injury, neonatal lung injury and bronchopulmonary dysplasia, post-infectious hydrocephalus, and hepatic fibrosis. A recurring limitation is that transplanted MSCs survive poorly and lose stable secretory function in hostile microenvironments such as the infarcted heart, and the cells are themselves prone to cellular senescence with expansion and donor age. Much current work therefore targets the delivery context — hydrogels and microgels of tuned stiffness, decellularized extracellular matrix, chitosan and other biomaterial carriers, aptamer-based enrichment of endogenous cells, and priming agents such as platelet-rich plasma or melatonin — to enrich, retain, and sustain MSC function at the injury site, or on using MSC-derived extracellular vesicles as a cell-free alternative.
Where the papers sit
23 papers from the last 6 months study mesenchymal stem cell directly · updated from PubMed 16 Nov 2026
Study type 1 clinical trial · 4 observational · 1 human data · 16 preclinical · 1 unclassified
Themes one subject · 1 new direction
Those 23 are all about one subject.
-
Regenerative Cell Therapy
Regenerative cell therapy is being applied across inflammatory disease, tissue injury, developmental lung disease, bone repair and neurodegeneration. Work increasingly pairs cells with retinoic acid, hydrogels, nanoparticles or surface engineering to improve survival, localization and function. Mechanistic studies emphasize immunometabolic reprogramming and donor- or patient-dependent response, while imaging tracks persistence after delivery. Early clinical studies in bronchopulmonary dysplasia, graft-versus-host disease and hydrocephalus are moving translation forward, but efficacy remains indication-specific.
MSCs are modeled as a functional hematopoietic niche rather than primarily administered as therapy
The microgel bone marrow model of MSC paracrine signaling supporting hematopoietic stem cell retention uses hydrogel-encapsulated MSCs to recreate a multicellular bone-marrow environment. Whereas the other papers mainly treat MSCs as therapeutic cells, engineered graft components, or sources of regenerative factors, this study makes MSCs themselves part of an ex vivo niche that maintains long-term repopulating hematopoietic stem cells. MSC density increased hematopoietic stem-cell maintenance, and microgel encapsulation promoted niche-favorable MSC transcriptional profiles, shifting the role of MSCs from therapeutic payload to tissue-supporting infrastructure for hematopoietic stem-cell retention and culture 42248284Jun.
Papers
The 23 papers from the last 6 months that study mesenchymal stem cell directly, newest first, by theme and by study type. Study types come from PubMed publication types and MeSH headings.
By theme
Regenerative Cell Therapy (23)
- The systemic administration of multipotent mesenchymal stromal cells alters the inflammatory response in the lung during murine polymicrobial sepsis. Cell and tissue research · 31 Oct 2026 PMID 42963429
- Can mesenchymal stem cell and retinoic acid therapies more effectively reduce lung damage due to bronchopulmonary dysplasia? Italian journal of pediatrics · 23 Oct 2026 PMID 42920189
- Mesenchymal Stromal Cells Fuel Immunometabolic Reprogramming of Type 2 Conventional Dendritic Cells to Alleviate Systemic Sclerosis. Arthritis & rheumatology (Hoboken, N.J.) · 5 Oct 2026 PMID 42834011
- ABCB5⁺ mesenchymal stem cells enable high-ratio cellular augmentation of bone grafts without loss of osteogenic function. European journal of trauma and emergency surgery : official publication of the European Trauma Society · 3 Sept 2026 PMID 42690432
- Remodeling-phase wound-derived protein factors enhance mesenchymal stem cell function and improve diabetic wound healing. Molecular biology reports · 3 Sept 2026 PMID 42690285
- Retrospective comparison of mesenchymal stromal cells and antithymocyte globulin as second-line therapy for acute graft-versus-host disease. Cytotherapy · 2 Sept 2026 PMID 42685638
- Gelatin Methacrylate as a Mesenchymal Stem Cell Delivery Vehicle: Experimental and Semi-Quantitative Evaluation Under Metabolic Stress. Macromolecular bioscience · 2 Sept 2026 PMID 42683595
- High-intensity interval training versus mesenchymal stem cells in amyloid-β-induced Alzheimer's disease: comparative effects on cognitive function,hippocampal inflammation, oxidative balance, and BDNF. Biochemical and biophysical research communications · 27 Aug 2026 PMID 42659862
- Dual-Reporter Gene-Based Multimodal Imaging for Tracking Mesenchymal Stem Cells in Diabetic Skin Wound Repair. Stem cell reviews and reports · 12 Aug 2026 PMID 42584542
- Responders vs. non-responders to mesenchymal stromal cells in knee osteoarthritis: Mechanistic correlates of donor cell and patient features. Stem cell reports · 6 Aug 2026 PMID 42561945
- Long-Term Survival, Illness Severity, and Time-to-Treatment Analysis in Dogs with Immune-Mediated Hemolytic Anemia Following Intravenous Allogeneic Mesenchymal Stem Cell Therapy: A Multicohort Follow-Up Study. Stem cells and development · 17 Jul 2026 PMID 42466752
- Aptamer-functionalized stiff hydrogel for enhanced BMSC enrichment and osteogenesis. PloS one · 16 Jul 2026 PMID 42461853
- Helping Underdeveloped Lungs with Cells (HULC-2): mesenchymal stromal cells in extreme preterm infants at risk of developing bronchopulmonary dysplasia - a study protocol of a phase 2 multicentre double blind randomised controlled trial in Canada. BMJ open · 6 Jul 2026 PMID 42409407
- A one-step surface engineering strategy based on PEG-EGCG to improve systemic delivery and survival of transplanted mesenchymal stromal cells. Journal of controlled release : official journal of the Controlled Release Society · 2 Jul 2026 PMID 42392407
- An injectable nanoreinforced hydrogel for combined GDNF-loaded nanoparticles and mesenchymal stem cell therapy in Parkinson's disease. European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences · 1 Jul 2026 PMID 42386013
- Intraventricular administration of SHED-derived mesenchymal stem cells in neonatal post- infectious hydrocephalus: a first-in-human case report. Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery · 26 Jun 2026 PMID 42362959
- Systemic mesenchymal stem cell therapy for reduction of inflammatory burden in a patient with juvenile-onset rheumatoid arthritis and dialysis-dependent renal failure. Croatian medical journal · 13 Jun 2026 PMID 42286909
- Bioprinted dECM particles-laden microgels enhance the mesenchymal stromal cell paracrine effect for myocardial infarction treatment. Acta biomaterialia · 6 Jun 2026 PMID 42250666
- A microgel bone marrow model of mesenchymal stromal cell paracrine signaling supporting hematopoietic stem cell retention. Acta biomaterialia · 5 Jun 2026 PMID 42248284
- TLR9 agonists alleviate diabetic condition by promoting the maturation of differentiated bone marrow mesenchymal stem cells in rats. Pakistan journal of pharmaceutical sciences · 22 May 2026 PMID 42170982
- Hypoxia-preconditioned bone marrow mesenchymal stem cells alleviate acute liver failure in association with the VEGF/c-Met pathway. Molecular biology reports · 21 May 2026 PMID 42165955
- Platelet-rich plasma-primed bone marrow mesenchymal stem cell-derived exosomes inhibit neuronal apoptosis and autophagy, and promote nerve regeneration via the miR-29a-3p/PTEN/PI3K/Akt/mTOR axis after spinal cord injury. Journal of molecular histology · 21 May 2026 PMID 42165939
- Heat shock preconditioning potentiates the therapeutic efficacy of mesenchymal stem cells for traumatic brain injury. Biochemical and biophysical research communications · 20 May 2026 PMID 42161062
By study type
Clinical trials (1)
- Helping Underdeveloped Lungs with Cells (HULC-2): mesenchymal stromal cells in extreme preterm infants at risk of developing bronchopulmonary dysplasia - a study protocol of a phase 2 multicentre double blind randomised controlled trial in Canada. BMJ open · 6 Jul 2026 PMID 42409407
Observational studies and case reports (4)
- Retrospective comparison of mesenchymal stromal cells and antithymocyte globulin as second-line therapy for acute graft-versus-host disease. Cytotherapy · 2 Sept 2026 PMID 42685638
- Long-Term Survival, Illness Severity, and Time-to-Treatment Analysis in Dogs with Immune-Mediated Hemolytic Anemia Following Intravenous Allogeneic Mesenchymal Stem Cell Therapy: A Multicohort Follow-Up Study. Stem cells and development · 17 Jul 2026 PMID 42466752
- Intraventricular administration of SHED-derived mesenchymal stem cells in neonatal post- infectious hydrocephalus: a first-in-human case report. Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery · 26 Jun 2026 PMID 42362959
- Systemic mesenchymal stem cell therapy for reduction of inflammatory burden in a patient with juvenile-onset rheumatoid arthritis and dialysis-dependent renal failure. Croatian medical journal · 13 Jun 2026 PMID 42286909
Human data, design not indexed (1)
- Responders vs. non-responders to mesenchymal stromal cells in knee osteoarthritis: Mechanistic correlates of donor cell and patient features. Stem cell reports · 6 Aug 2026 PMID 42561945
Preclinical: animal, cell and lab studies (16)
- The systemic administration of multipotent mesenchymal stromal cells alters the inflammatory response in the lung during murine polymicrobial sepsis. Cell and tissue research · 31 Oct 2026 PMID 42963429
- Can mesenchymal stem cell and retinoic acid therapies more effectively reduce lung damage due to bronchopulmonary dysplasia? Italian journal of pediatrics · 23 Oct 2026 PMID 42920189
- ABCB5⁺ mesenchymal stem cells enable high-ratio cellular augmentation of bone grafts without loss of osteogenic function. European journal of trauma and emergency surgery : official publication of the European Trauma Society · 3 Sept 2026 PMID 42690432
- Remodeling-phase wound-derived protein factors enhance mesenchymal stem cell function and improve diabetic wound healing. Molecular biology reports · 3 Sept 2026 PMID 42690285
- Gelatin Methacrylate as a Mesenchymal Stem Cell Delivery Vehicle: Experimental and Semi-Quantitative Evaluation Under Metabolic Stress. Macromolecular bioscience · 2 Sept 2026 PMID 42683595
- High-intensity interval training versus mesenchymal stem cells in amyloid-β-induced Alzheimer's disease: comparative effects on cognitive function,hippocampal inflammation, oxidative balance, and BDNF. Biochemical and biophysical research communications · 27 Aug 2026 PMID 42659862
- Dual-Reporter Gene-Based Multimodal Imaging for Tracking Mesenchymal Stem Cells in Diabetic Skin Wound Repair. Stem cell reviews and reports · 12 Aug 2026 PMID 42584542
- Aptamer-functionalized stiff hydrogel for enhanced BMSC enrichment and osteogenesis. PloS one · 16 Jul 2026 PMID 42461853
- A one-step surface engineering strategy based on PEG-EGCG to improve systemic delivery and survival of transplanted mesenchymal stromal cells. Journal of controlled release : official journal of the Controlled Release Society · 2 Jul 2026 PMID 42392407
- An injectable nanoreinforced hydrogel for combined GDNF-loaded nanoparticles and mesenchymal stem cell therapy in Parkinson's disease. European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences · 1 Jul 2026 PMID 42386013
- Bioprinted dECM particles-laden microgels enhance the mesenchymal stromal cell paracrine effect for myocardial infarction treatment. Acta biomaterialia · 6 Jun 2026 PMID 42250666
- A microgel bone marrow model of mesenchymal stromal cell paracrine signaling supporting hematopoietic stem cell retention. Acta biomaterialia · 5 Jun 2026 PMID 42248284
- TLR9 agonists alleviate diabetic condition by promoting the maturation of differentiated bone marrow mesenchymal stem cells in rats. Pakistan journal of pharmaceutical sciences · 22 May 2026 PMID 42170982
- Hypoxia-preconditioned bone marrow mesenchymal stem cells alleviate acute liver failure in association with the VEGF/c-Met pathway. Molecular biology reports · 21 May 2026 PMID 42165955
- Platelet-rich plasma-primed bone marrow mesenchymal stem cell-derived exosomes inhibit neuronal apoptosis and autophagy, and promote nerve regeneration via the miR-29a-3p/PTEN/PI3K/Akt/mTOR axis after spinal cord injury. Journal of molecular histology · 21 May 2026 PMID 42165939
- Heat shock preconditioning potentiates the therapeutic efficacy of mesenchymal stem cells for traumatic brain injury. Biochemical and biophysical research communications · 20 May 2026 PMID 42161062
Unclassified: not yet indexed with MeSH (1)
- Mesenchymal Stromal Cells Fuel Immunometabolic Reprogramming of Type 2 Conventional Dendritic Cells to Alleviate Systemic Sclerosis. Arthritis & rheumatology (Hoboken, N.J.) · 5 Oct 2026 PMID 42834011
Written from 23 PubMed abstracts, each one listed by PMID above. Published: 2026-07-02. Last written: 2026-09-05 by GPT. Reviewed by a human editor on 2026-07-24. Drafted by language models from published abstracts; not medical advice.